| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/19/2004 | US20040033237 Immunogenicity using a combination of dna and vaccinia virus vector vaccines |
| 02/19/2004 | US20040033235 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 02/19/2004 | US20040033233 Dried powder form in sachet or in capsule of root, bark and wood of Philippine Narra tree (Pterocarpus Indicus) |
| 02/19/2004 | US20040033229 PSMA antibodies and protein multimers |
| 02/19/2004 | US20040031447 Animal papilla disinfectants and method of improving microbial environment |
| 02/19/2004 | DE10238534A1 Zusammensetzung Composition |
| 02/19/2004 | DE10236340A1 New heteroar(alkan)oyl-substituted phenyl-beta-alaninamide derivatives, useful as broad-spectrum antibacterial agents in human or veterinary medicine |
| 02/19/2004 | CA2497662A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 02/19/2004 | CA2495725A1 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody |
| 02/19/2004 | CA2495684A1 Use of n-acetyl-d-glucosamine in the manufacture of a medicament for treating urogenital tract infection |
| 02/19/2004 | CA2495518A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/19/2004 | CA2495456A1 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 02/19/2004 | CA2495116A1 Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof |
| 02/19/2004 | CA2494865A1 Electrospun amorphous pharmaceutical compositions |
| 02/19/2004 | CA2494827A1 Cannabinoid receptor ligands |
| 02/19/2004 | CA2494742A1 Tiacumicin production |
| 02/19/2004 | CA2494623A1 Polyisoprenylbenzophenone derivatives, method for production and use thereof |
| 02/19/2004 | CA2494258A1 The use of fermented wheat-germ in the feeding and veterinary practice |
| 02/19/2004 | CA2494193A1 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
| 02/19/2004 | CA2494028A1 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 02/19/2004 | CA2494026A1 Phosphodiesterase 4 inhibitors |
| 02/19/2004 | CA2493660A1 Process for preparing quinolin antibiotic intermediates |
| 02/19/2004 | CA2493625A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/19/2004 | CA2493297A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 02/19/2004 | CA2493146A1 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 02/19/2004 | CA2492940A1 Novel difluorinated gem compounds, preparation methods thereof and applications of same |
| 02/19/2004 | CA2491287A1 N-aryl-2-oxazolidinones and their derivatives |
| 02/18/2004 | EP1389619A1 Pkb-3564 substance with neovascularization inhibitory activity |
| 02/18/2004 | EP1389466A1 Immunopotentiators |
| 02/18/2004 | EP1389463A1 Medicine for inhibiting drug elimination pump |
| 02/18/2004 | EP1389462A1 Amorphous cefditoren pivoxil composition and process for producing the same |
| 02/18/2004 | EP1389461A1 Pyrimidones with antiviral properties |
| 02/18/2004 | EP1389234A2 Cd8alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 02/18/2004 | EP1389207A1 Polymorphic and other crystalline forms of cis-ftc |
| 02/18/2004 | EP1389206A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 02/18/2004 | EP1389204A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 02/18/2004 | EP1389137A2 Compositions for protein delivery via the pulmonary route |
| 02/18/2004 | EP1389129A1 Methods of treating respiratory conditions |
| 02/18/2004 | EP1389120A2 Identifying parasitic fungi of the organism, and treatment thereof |
| 02/18/2004 | EP1389119A1 A pharmaceutical composition comprising lysophosphatidic acid |
| 02/18/2004 | EP1389111A1 COMPOSITION FOR INHIBITING HIV ACTIVITY EXTRACTED FROM i PAECILOMYCES SP. /i (TOCHU-KASO) J300 |
| 02/18/2004 | EP1389107A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors |
| 02/18/2004 | EP1389103A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 02/18/2004 | EP1389099A1 Delivery of beta-blockers through an inhalation route |
| 02/18/2004 | EP1389098A1 Delivery of antipsychotics through an inhalation route |
| 02/18/2004 | EP1389097A1 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 02/18/2004 | EP1389096A1 Delivery of opioids through an inhalation route |
| 02/18/2004 | EP1389095A1 Delivery of antidepressants through an inhalation route |
| 02/18/2004 | EP1389094A1 Delivery of sedative-hypnotics trough an inhalation route |
| 02/18/2004 | EP1389089A2 Method and composition for solubilising a biologically active compound with low water solubility |
| 02/18/2004 | EP1389043A1 Foot and mouth disease virus vaccine |
| 02/18/2004 | EP1267932B1 Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails |
| 02/18/2004 | EP1233786B1 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance for the preparation of a medicament |
| 02/18/2004 | EP1216238B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 02/18/2004 | EP1196410B1 Respiratory syncytial virus replication inhibitors |
| 02/18/2004 | EP1178736B1 A composition containing carvacrol and thymol for use as a bactericide |
| 02/18/2004 | EP1163256B1 Hemihydrate of 16.alpha.-bromoepiandrosterone |
| 02/18/2004 | EP1133494B1 8-azabicyclo 3.2.1]oct-2-ene and -octane derivatives |
| 02/18/2004 | EP1133477B1 Substituted benzimidazoles and their use as parp inhibitors |
| 02/18/2004 | EP1119568B1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 02/18/2004 | EP1104422B1 Phenyl xanthine derivatives |
| 02/18/2004 | EP1089755B1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 02/18/2004 | EP1000086B1 Alatrofloxacin parenteral compositions |
| 02/18/2004 | EP0983271B1 Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
| 02/18/2004 | EP0983270B1 Process for preparing 6-o-monoesters of castanospermine |
| 02/18/2004 | EP0876388B1 Tricyclic erythromycin derivatives |
| 02/18/2004 | EP0851857B1 Inhibitors of tumor necrosis factor alpha |
| 02/18/2004 | EP0817851B1 Dna encoding human papilloma virus type 18 |
| 02/18/2004 | CN1476476A Ligand/receptor specificity exchangers that redirect antibodies to receptors on pathogen |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1476442A Pyridine derivatives with IKB-kinase (IKK-beta) INhibiting activity |
| 02/18/2004 | CN1476436A Novel compounds for use as HIV protease inhibitors |
| 02/18/2004 | CN1476432A Indole and dihydroindole derivatives |
| 02/18/2004 | CN1476329A Bactericidal disinfectant, antibacterial drug and antibacterial material |
| 02/18/2004 | CN1475571A Expression of recombination SARS virus gene in pleiomorphic Hansen yeast and its use |
| 02/18/2004 | CN1475505A Human composite type alpha interferon protein N terminal tag structure |
| 02/18/2004 | CN1475488A Fluoro isoflavone containing derivative, monufacturing method and its use |
| 02/18/2004 | CN1475487A Fluoro flavon containing compound, manufacturing method and its use |
| 02/18/2004 | CN1475275A Mannan peptide freeze dried powder ampoule for injection |
| 02/18/2004 | CN1475269A Rhizoma cimicifugae extract and its preparation method |
| 02/18/2004 | CN1475265A Medicament box used for treating acute anhelation syndrome |
| 02/18/2004 | CN1475264A New use of qingkailing preparation in treating of acute anhelation syndrome |
| 02/18/2004 | CN1475260A Chinese medicinal prescription for treating dermatosis |
| 02/18/2004 | CN1475259A Compound ganmaoling tablet (film coating tablet for treating common cold) and its manufacturing method |
| 02/18/2004 | CN1475250A Multiuse pure natural plant preparation |
| 02/18/2004 | CN1475244A Antivirus oral liquid |
| 02/18/2004 | CN1475225A Use of Bacille Calmette-Guerin polysaccharide nucleic acid in the preparation of medicine for oral cavity local administration |
| 02/18/2004 | CN1475224A Compound preparation of levocarnitin and adenosine triphosphate |
| 02/18/2004 | CN1475223A Compound preparation containing ribavirin and new decanoy acetaldehyde sodium and its preparation method |
| 02/18/2004 | CN1475217A Application of N-acetyl-D-aminoglucose in the preparation of medicine for treating urogenital system infection |
| 02/18/2004 | CN1475215A Enosaxin for injection and its preparation method |
| 02/18/2004 | CN1475212A Compound preparation of levocarnitine and calcium pantothenate |
| 02/18/2004 | CN1475211A Compound preparation of levocarnitine and coenzyme Q10 |
| 02/18/2004 | CN1138787C Natural plant polyose |
| 02/18/2004 | CN1138774C Substituted 6,6-hetero-bicyclic derivatives |
| 02/18/2004 | CN1138765C Oxazolidinone antibacterial agents having thiocarbonyl functionality |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/18/2004 | CN1138656C Drive system and vehicle rear-view mirror using the same |
| 02/18/2004 | CN1138579C Diffusional implantable delivery system |
| 02/18/2004 | CN1138564C Influenza vaccine |